News Detail
New Delhi, 25 Sept 2023: The Central Drugs Standard Control Organisation (CDSCO) has declared the samples of Cipla's benign prostatic hyperplasia drug Urimax D it tested in July as spurious drug, and is investigating on Sun Pharma Laboratories' tip off that its bad cholesterol lo......
View Details
Source : Pharmabiz
CDSCO
Cipla
prostatic hyperplasia drug
Urimax D
spurious drug
Sun Pharma
cholesterol
Rosuvas 10
Not of Standard Quality
NSQ
Mankind Pharma
Intas Pharmaceuticals
KAPL
tamsulosin hydrochloride
dutasteride
Urimax D
Drugs and Cosmetics Act
antidiabetic
Glimestar M2 Forte
Mankind Pharma
Amtas PRP
Adani Wilmar
Related News
- No mandatory time duration prescribed for sampling of psychotropic substances under NDPS Act (03-12-2023)
- Florida Medical Clinic Owner and Pharmacy Technician Sentenced to Prison in Clinical Trial Fraud Scheme (03-12-2023)
- Seven arrested following six fatalities linked to Ayurvedic 'Kalmeghasav' consumption in Gujarat (03-12-2023)
- Only D Pharma eligible to become pharmacists in govt depts (03-12-2023)
- HC junks Sunil Chaudhary's anticipatory bail plea in bribery case (03-12-2023)
- Chowki Basdei Police arrested supplier of drug injection from Bihar (02-12-2023)
- Two arrested including doctor for drug smuggling, banned medicines recovered (02-12-2023)
- HC disposes of PILs on NAT-PCR in blood banks (02-12-2023)
- Japan to tighten regulations on over-the-counter drug sales (02-12-2023)
- Mumbai: Crime Branch Unit 3 Busts Fake Doctor Gang Exploiting Unani Ayurvedic Treatment (02-12-2023)